Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase
Clinical trial NCT00514969 · COMPLETED
Trial details
- NCT number
- NCT00514969
- Sponsor
- University of Bologna
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.